location: Current position: Home-Yong Liu >> Scientific Research >> Paper Publications

Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.

Hits:

Journal:Toxicology and applied pharmacology

Volume:466

Page Number:116490

ISSN No.:0041-008X

Key Words:Drug-drug interaction; In vitro-in vivo extrapolation; Ripretinib; UDP-glucuronosyltransferase

Pre One:Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis.

Next One:Higher risk of hepatotoxicity associated with cabozantinib in cancer patients